Skip to contentC
Core Scientific, Inc./tx
C
CORZZCore Scientific, Inc./tx Q1 2026 · 10-Q
Revenue$115.24M$115.24M+44.9% vs Q1 2025 Net Income-$347.19M-$347.19MN/M vs Q1 2025 EPS Diluted-$1.06-$1.06N/M vs Q1 2025 Gross Profit$30,106,000+266.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Core Scientific, Inc./tx · CIK 1839341 · Engraved from SEC EDGAR
Operating Cash Flow$249,877,000N/M Free Cash Flowderived-$139,349,000N/M Margins · derivedGross margin26.1%+15.8 pt vs Q1 2025
Operating margin-269.4%−210.2 pt vs Q1 2025
Net margin-301.3%
ended Mar 31, 2026 · filed May 6, 2026 · 36 d after period end